FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884293145> ?p ?o ?g. }

• W2884293145 endingPage "496" @default.
• W2884293145 startingPage "488" @default.
• W2884293145 abstract "The presence of a donor-specific positive crossmatch has been considered to be a contraindication to kidney transplantation because of the risk of hyperacute rejection. Desensitization is the process of removing hazardous preformed donor-specific antibody (DSA) in order to safely proceed with transplant. Traditionally, this involves plasmapheresis and intravenous immune globulin treatments that occur over days to weeks, and has been feasible when there is a living donor and the date of the transplant is known, allowing time for pre-emptive treatments. For sensitized patients without a living donor, transplantation has been historically difficult.IdeS (imlifidase) is an endopeptidase derived from Streptococcus pyogenes which has specificity for human IgG, and when infused intravenously results in rapid cleavage of IgG.Here we present our single-center's experience with 7 highly sensitized (cPRA98-100%) kidney transplant candidates who had DSA resulting in positive crossmatches with their donors (5 deceased, 2 living) who received IdeS within 24 hours prior to transplant.All pre-IdeS crossmatches were positive and would have been prohibitive for transplantation. All crossmatches became negative post-IdeS and the patients underwent successful transplantation. Three patients had DSA rebound and antibody-mediated rejection, which responded to standard of care therapies. Three patients had delayed graft function, which ultimately resolved. No serious adverse events were associated with IdeS. All patients have functioning renal allografts at a median follow-up of 235 days.IdeS may represent a groundbreaking new method of desensitization for patients who otherwise might have no hope for receiving a lifesaving transplant." @default.
• W2884293145 created "2018-08-03" @default.
• W2884293145 creator A5013485133 @default.
• W2884293145 creator A5032906001 @default.
• W2884293145 creator A5033899520 @default.
• W2884293145 creator A5046487175 @default.
• W2884293145 creator A5057778893 @default.
• W2884293145 creator A5059225494 @default.
• W2884293145 creator A5060590497 @default.
• W2884293145 creator A5068536366 @default.
• W2884293145 creator A5081908264 @default.
• W2884293145 creator A5088082671 @default.
• W2884293145 creator A5088249181 @default.
• W2884293145 date "2018-09-01" @default.
• W2884293145 modified "2023-10-01" @default.
• W2884293145 title "IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody" @default.
• W2884293145 cites W1744376040 @default.
• W2884293145 cites W1971519043 @default.
• W2884293145 cites W1995693274 @default.
• W2884293145 cites W1999123359 @default.
• W2884293145 cites W2009704613 @default.
• W2884293145 cites W2076843879 @default.
• W2884293145 cites W2092072237 @default.
• W2884293145 cites W2092628378 @default.
• W2884293145 cites W2103609427 @default.
• W2884293145 cites W2116180543 @default.
• W2884293145 cites W2149910352 @default.
• W2884293145 cites W2165521792 @default.
• W2884293145 cites W2166232847 @default.
• W2884293145 cites W2308498913 @default.
• W2884293145 cites W2552263672 @default.
• W2884293145 cites W2606091185 @default.
• W2884293145 cites W2740266422 @default.
• W2884293145 cites W2779784325 @default.
• W2884293145 cites W915184378 @default.
• W2884293145 doi "https://doi.org/10.1097/sla.0000000000002924" @default.
• W2884293145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30004918" @default.
• W2884293145 hasPublicationYear "2018" @default.
• W2884293145 type Work @default.
• W2884293145 sameAs 2884293145 @default.
• W2884293145 citedByCount "68" @default.
• W2884293145 countsByYear W28842931452018 @default.
• W2884293145 countsByYear W28842931452019 @default.
• W2884293145 countsByYear W28842931452020 @default.
• W2884293145 countsByYear W28842931452021 @default.
• W2884293145 countsByYear W28842931452022 @default.
• W2884293145 countsByYear W28842931452023 @default.
• W2884293145 crossrefType "journal-article" @default.
• W2884293145 hasAuthorship W2884293145A5013485133 @default.
• W2884293145 hasAuthorship W2884293145A5032906001 @default.
• W2884293145 hasAuthorship W2884293145A5033899520 @default.
• W2884293145 hasAuthorship W2884293145A5046487175 @default.
• W2884293145 hasAuthorship W2884293145A5057778893 @default.
• W2884293145 hasAuthorship W2884293145A5059225494 @default.
• W2884293145 hasAuthorship W2884293145A5060590497 @default.
• W2884293145 hasAuthorship W2884293145A5068536366 @default.
• W2884293145 hasAuthorship W2884293145A5081908264 @default.
• W2884293145 hasAuthorship W2884293145A5088082671 @default.
• W2884293145 hasAuthorship W2884293145A5088249181 @default.
• W2884293145 hasConcept C126322002 @default.
• W2884293145 hasConcept C126894567 @default.
• W2884293145 hasConcept C141071460 @default.
• W2884293145 hasConcept C142724271 @default.
• W2884293145 hasConcept C159654299 @default.
• W2884293145 hasConcept C170493617 @default.
• W2884293145 hasConcept C197934379 @default.
• W2884293145 hasConcept C203014093 @default.
• W2884293145 hasConcept C204787440 @default.
• W2884293145 hasConcept C2776494729 @default.
• W2884293145 hasConcept C2778842783 @default.
• W2884293145 hasConcept C2779779143 @default.
• W2884293145 hasConcept C2780303639 @default.
• W2884293145 hasConcept C2911091166 @default.
• W2884293145 hasConcept C71924100 @default.
• W2884293145 hasConceptScore W2884293145C126322002 @default.
• W2884293145 hasConceptScore W2884293145C126894567 @default.
• W2884293145 hasConceptScore W2884293145C141071460 @default.
• W2884293145 hasConceptScore W2884293145C142724271 @default.
• W2884293145 hasConceptScore W2884293145C159654299 @default.
• W2884293145 hasConceptScore W2884293145C170493617 @default.
• W2884293145 hasConceptScore W2884293145C197934379 @default.
• W2884293145 hasConceptScore W2884293145C203014093 @default.
• W2884293145 hasConceptScore W2884293145C204787440 @default.
• W2884293145 hasConceptScore W2884293145C2776494729 @default.
• W2884293145 hasConceptScore W2884293145C2778842783 @default.
• W2884293145 hasConceptScore W2884293145C2779779143 @default.
• W2884293145 hasConceptScore W2884293145C2780303639 @default.
• W2884293145 hasConceptScore W2884293145C2911091166 @default.
• W2884293145 hasConceptScore W2884293145C71924100 @default.
• W2884293145 hasIssue "3" @default.
• W2884293145 hasLocation W28842931451 @default.
• W2884293145 hasLocation W28842931452 @default.
• W2884293145 hasOpenAccess W2884293145 @default.
• W2884293145 hasPrimaryLocation W28842931451 @default.
• W2884293145 hasRelatedWork W1875739525 @default.
• W2884293145 hasRelatedWork W1999123359 @default.
• W2884293145 hasRelatedWork W2105297534 @default.
• W2884293145 hasRelatedWork W2347402321 @default.

• next